The project is set to attract significant manufacturing investments of approximately Rs. 10,500 crore and is also projected to create around 1 lakh direct and indirect jobs
The company will receive GMP compliance certificate which will further help to accelerate the business growth across the globe
The FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit
The group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode
These initiatives signify a substantial boost to healthcare infrastructure across India, aligned with the Prime Minister’s mission of ensuring quality healthcare services nationwide
Eugia Steriles receives EIR from USFDA for new injectable facility
The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
Ami informs that PMDA Japan has issued Inspection Result Report declaring the Sachin facility as a Good Manufacturing Practices (GMP) compliant.
Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs. 30 crores during FY 2024 and Rs. 7 crores in Q1 FY 2025
Subscribe To Our Newsletter & Stay Updated
